NCT03250052View on ClinicalTrials.gov

A Clinical Trial to Evaluate Pharmacokinetic Interactions and Safety Between Fimasartan and Linagliptin in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

August 14, 2017

Primary Completion Date

October 13, 2017

Study Completion Date

November 21, 2017

Conditions
Hypertension
Interventions
DRUG

(fimasartan or linagliptin) x 7days

Part A: fimasartan, Part B: linagliptin

DRUG

(fimasartan and linagliptin) x 7days

Part A \& Part B: Co-administration of fimasartan and linagliptin

Trial Locations (1)

Unknown

Kyungpook National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY